Tsai Hsiang-Lin, Lu Chien-Yu, Hsieh Jan-Sing, Wu Deng-Chyang, Jan Chang-Ming, Chai Chee-Yin, Chu Koung Shing, Chan Hon-Man, Wang Jaw-Yuan
Department of Surgery, Kaohsiung Medical University Hospital, 100 Tzyou 1st Road, Kaohsiung 807, Taiwan.
J Gastrointest Surg. 2007 May;11(5):660-5. doi: 10.1007/s11605-007-0119-x.
In patients with radically resected colorectal carcinoma, lymph node involvement is particularly important for a good prognosis and adjuvant therapy. The number of such lymph node recoveries is still controversial, with recommendations ranging from 6 to 17 nodes. The aim of this study is to determine if a specified minimum number of lymph nodes examined per surgical specimen can have any effect on the prognosis of patients who have undergone curative resection for T(2-4)N(0)M(0) colorectal carcinoma. Between September 1999 and January 2005, a total of 366 patients who underwent radical resection for T(2-4)N(0)M(0) colorectal carcinoma were retrospectively analyzed in a single institution. All specimen segments were fixed, with node identification performed by sight and palpation. We excluded 186 patients who received postoperative adjuvant chemotherapy via oral or intravenous transmission to prevent possible chemotherapeutic effects on patients' prognosis; therefore, a total of 180 patients with T(2-4)N(0)M(0) colorectal carcinoma were enrolled into this study. After the pathological examination, a mean of 12 lymph nodes (range 0-66) was harvested per tumor specimen. No postoperative relapse was found in this group, where the number of examined lymph nodes was 18 or more. Univariate analysis identified the size of the tumor, depth of invasion, grade of tumor, and number of examined lymph nodes, which were significantly correlated with postoperative relapse (all P < 0.05). Meanwhile, both the depth of tumor invasion and the number of harvested lymph nodes were independent predictors for postoperative relapse (P < 0.05). The 5-year overall survival rate of T(2-4)N(0)M(0) colorectal carcinoma patients who had 18 or more lymph nodes examined was significantly higher than those who had less than 18 nodes examined (P = 0.015). Nodal harvest in patients undergoing radical resection for colorectal carcinoma was highly significant in the current investigation. Our results suggest that harvesting and examining a minimum of 18 lymph nodes per surgical specimen might be taken into consideration for more reliable staging of lymph node-negative colorectal carcinoma.
在接受根治性切除的结直肠癌患者中,淋巴结受累情况对良好预后及辅助治疗尤为重要。此类淋巴结回收数量仍存在争议,推荐数量从6个至17个不等。本研究的目的是确定每个手术标本检查的特定最少淋巴结数量是否会对接受T(2 - 4)N(0)M(0)期结直肠癌根治性切除患者的预后产生影响。在1999年9月至2005年1月期间,对一家机构中366例接受T(2 - 4)N(0)M(0)期结直肠癌根治性切除的患者进行了回顾性分析。所有标本段均进行固定,通过肉眼观察和触诊识别淋巴结。我们排除了186例通过口服或静脉途径接受术后辅助化疗的患者,以防止化疗对患者预后可能产生的影响;因此,共有180例T(2 - 4)N(0)M(0)期结直肠癌患者纳入本研究。病理检查后,每个肿瘤标本平均回收12个淋巴结(范围为0至66个)。该组中未发现术后复发情况,其中检查的淋巴结数量为18个或更多。单因素分析确定肿瘤大小、浸润深度、肿瘤分级和检查的淋巴结数量与术后复发显著相关(所有P < 0.05)。同时,肿瘤浸润深度和回收的淋巴结数量均为术后复发的独立预测因素(P < 0.05)。检查的淋巴结数量为18个或更多的T(2 - 4)N(0)M(0)期结直肠癌患者的5年总生存率显著高于检查的淋巴结数量少于18个的患者(P = 0.015)。在当前研究中,接受结直肠癌根治性切除患者的淋巴结回收具有高度显著性。我们的结果表明,为了更可靠地对淋巴结阴性的结直肠癌进行分期,可能需要考虑每个手术标本最少回收并检查18个淋巴结。